Loading Events

« All Events

  • This event has passed.

Causal Inference in Drug Development: Why, When, How?

August 21 @ 8:30 - 16:00


08:30 – 9:00 Registration

09:00 – 9:10 Welcome from the organizing committee

9:10-10:40 Causal Inference in Drug Development – Why or why not

(Session chair: N.N.)

What you need to know (Miguel Hernan, Harvard)

Relation to ICH E9 (Christine Fletcher, Amgen)

A regulator’s perspective (Frank Pétavy, EMA)

10:40 – 11:10 Coffee break

11:10 – 12:30 Case studies 1 (Session chair: Giusi Moffa, University of Basel) Adverse reactions confounded by prior medication: (how) can causal inference solve the problem? (Valentine Jehl, Novartis)

Treatment sequencing and effectiveness: challenges and considerations (Thibaut Sanglier, Roche)

12:30 – 13:20 Lunch

13:20 – 14:40 Case studies 2 (Session chair: N.N.)

Principal stratification techniques in the context of regulatory decision making (Nikolaos Sfikas, Novartis)

Estimating treatment effects in the pharmaceutical arena using instrumental variable methods: from “academic” causal inference to the Estimand Framework via the CANTOS study (Jack Bowden, University of Bristol)

14:40 – 15:00 Coffee break

15:00 – 16:00 Panel discussion: Where do we go from here?

Session chairs: Sigrid Behr, Novartis and N.N. Including all Speakers

16:00 Closure of the meeting



August 21
8:30 - 16:00


F Hoffmann-La Roche; Auditorium 2nd Floor
Grenzacherstrasse 124; Roche Building 001
Basel, 4053 Switzerland
+ Google Map